BGI Genomics Co., Ltd.

SZSE:300676.SZ

46.6 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 4,732.3765,157.7446,590.2875,430.072735.3271,070.061946.645748.643516.41508.247320.826352.909
Short Term Investments 753.5751,231.9472,049.07-116.101482.22-71.272-76.21-74.141-49.623-37.116-34.905-24.526
Cash and Short Term Investments 5,485.9516,389.6918,639.3575,430.0721,217.5471,070.061946.645748.643516.41508.247320.826352.909
Net Receivables 1,551.622,471.7641,373.6651,813.3921,560.4261,375.733890.386654.207536.321606.058500.785423.7
Inventory 602.182717.833877.7191,009.819342.972241.906138.58273.594111.40187.06167.38830.486
Other Current Assets 293.04186.449144.019163.65982.563594.1811,856.461,725.8981,882.89812.5142.9475.506
Total Current Assets 7,932.7939,765.73611,034.768,416.9433,203.5073,281.8813,832.0733,202.3423,047.031,213.88891.946812.601
Non-Current Assets:
Property, Plant & Equipment, Net 3,190.4232,190.3551,399.6951,287.3881,310.5851,152.522739.439556.64430.693407.524276.946135.809
Goodwill 47.10947.10947.10947.10947.10947.109000000
Intangible Assets 579.938528.954323.211179.369177.805160.424160.143171.666189.236203.254213.0370.121
Goodwill and Intangible Assets 627.048576.063370.321226.478224.915207.533160.143171.666189.236203.254213.0370.121
Long Term Investments 498.68296.416-1,150.859865.416130.867349.887293.959174.32775.25563.08135.40524.626
Tax Assets 241.579236.293200.286162.05593.54271.24548.8338.45338.77449.88549.06129.746
Other Non-Current Assets 1,122.4821,510.652,399.826236.76945.702188.33237.3786.667129.868111.28531.0070.774
Total Non-Current Assets 5,680.2154,609.7783,219.272,778.0982,705.6111,969.521,279.741,027.753863.827835.028605.456191.076
Total Assets 13,613.00814,375.51414,254.0311,195.0415,909.1185,251.45,111.8134,230.0943,910.8572,048.9081,497.4021,003.677
Liabilities & Equity:
Current Liabilities:
Account Payables 864.5951,024.844805.322873.231221.156139.034119.65857.92446.79845.1855.25137.775
Short Term Debt 812.979809.536153.767644.60356.61431.06338.71438.1297.312.450.9
Tax Payables 86.816125.265233.366296.57854.77366.83343.37536.22442.34126.63627.77215.203
Deferred Revenue 1,590.706928.6232,402.5952,248.689350.16266.833257.533222.309172.922127.819435.783453.124
Other Current Liabilities 28.761,180.93621.83335.599506.567707.382397.177448.247459.548350.739367.235341.072
Total Current Liabilities 3,297.043,943.9393,383.5173,802.1211,134.498944.313813.082731.48687.397531.047860.719832.871
Non-Current Liabilities:
Long Term Debt 283.427136.68716.403658.003301.38700001.9280-0
Deferred Revenue Non-Current 15.39319.67536.07449.10146.02433.02431.12442.75947.80842.32127.22914.259
Deferred Tax Liabilities Non-Current 13.12751.5625.1911.47926.176.7039.6723.2826.1658.10611.5096.176
Other Non-Current Liabilities 00671.572658.594015000000
Total Non-Current Liabilities 311.947207.9181,429.241,367.178373.58154.72740.79646.04153.97352.35538.73820.436
Total Liabilities 3,608.9884,151.8574,812.7565,169.31,508.079999.04853.878777.521741.37583.402899.457853.307
Equity:
Preferred Stock 0000000002.4961.060
Common Stock 413.914413.914413.914400.1400.1400.1400.136036085.859202
Retained Earnings 4,617.9854,941.3664,318.6983,020.478974.197861.887703.511428.887182.325-40.15947.15356.313
Accumulated Other Comprehensive Income/Loss 143.108478.251340.759199.227343.019311.152448.282,570.8752,552.693-2.496-1.060
Other Total Stockholders Equity 4,684.234,245.0364,245.0362,290.3012,596.7332,591.822,596.733001,140.246332.78454.931
Total Shareholders Equity 9,859.23810,078.5689,318.4085,910.1054,314.0494,164.964,148.6253,359.7623,095.0181,185.946399.936113.244
Total Equity 10,004.0210,223.6579,441.2736,025.7414,401.0394,252.364,257.9353,452.5733,169.4871,465.506597.945150.371
Total Liabilities & Shareholders Equity 13,613.00814,375.51414,254.0311,195.0415,909.1185,251.45,111.8134,230.0943,910.8572,048.9081,497.4021,003.677